The U. S. sex reassignment surgery market size is expected to reach USD 5.0 billion by 2030, growing at a CAGR of 11.25% from 2023 to 2030. Improving reimbursement scenario and government aids, and growing awareness about transgender surgeries is expected to drive the growth of the market over the forecast period. The rising awareness plays a crucial role in fostering understanding, acceptance, and support for transgender individuals. Gender-affirming hormone treatment involving the use of estrogen or testosterone plays a significant role in aligning the physical characteristics of transgender individuals with their gender identity.
Furthermore, the market is growing due to favorable government initiatives that provide care and financial aid for surgeries. Subsequently, in June 2021, Secretary Denis McDonough of the Department of Veterans Affairs (VA) announced at a pride event in Florida that transgender veterans in the U. S. would now have access to gender-affirming surgeries under the government's health care coverage. Before this, only hormone therapy and mental health services were included under the government's health care coverage. These favorable government initiatives are significant in propelling the expansion of the market.
The COVID-19 pandemic adversely affected the market for sex reassignment surgery in the U. S. Plastic surgeons reported a declining volume of services and procedures due to the pandemic's stringent regulations. Those who conducted cosmetic, gender affirmation, or other elective surgical procedures were primarily affected compared to those who performed craniofacial, reconstructive, and hand surgery. Such COVID-19-related surgical delays affected the market's overall growth during the pandemic. However, as clinics and hospitals around the U. S. have resumed non-emergency services, the demand for sex reassignment surgeries is expected to boost the growth of the market over the forecast period.
This product will be delivered within 1-3 business days.
Furthermore, the market is growing due to favorable government initiatives that provide care and financial aid for surgeries. Subsequently, in June 2021, Secretary Denis McDonough of the Department of Veterans Affairs (VA) announced at a pride event in Florida that transgender veterans in the U. S. would now have access to gender-affirming surgeries under the government's health care coverage. Before this, only hormone therapy and mental health services were included under the government's health care coverage. These favorable government initiatives are significant in propelling the expansion of the market.
The COVID-19 pandemic adversely affected the market for sex reassignment surgery in the U. S. Plastic surgeons reported a declining volume of services and procedures due to the pandemic's stringent regulations. Those who conducted cosmetic, gender affirmation, or other elective surgical procedures were primarily affected compared to those who performed craniofacial, reconstructive, and hand surgery. Such COVID-19-related surgical delays affected the market's overall growth during the pandemic. However, as clinics and hospitals around the U. S. have resumed non-emergency services, the demand for sex reassignment surgeries is expected to boost the growth of the market over the forecast period.
U. S. Sex Reassignment Surgery Market Report Highlights
- Based on the procedure segment, the mastectomies held the largest market share of 20.1% in terms of revenue in 2022. This increase can be attributed to the growing recognition of transgender identity and rights
- In terms of procedure, the augmentation mammoplasty segment is expected to witness the fastest CAGR over the forecast period owing to the growing affordability and availability of breast implants
- In terms of gender transition, the female-to-male gender transition segment dominated the market with the largest revenue share of 59.81% in 2022. The increasing number of transgender men opting for gender reassignment surgery due to positive outcomes and acceptance from society are primary factors driving segment growth
- The U. S. sex reassignment market is fragmented, with the presence of a few major players and a small number of small- & medium-sized care centers. The companies have undertaken numerous strategic initiatives to improve their services including sex reassignment surgery, leading to a significant market share. For instance, in April 2022, Cedars Sinai received an LGBTQ Health Care Equality Top Performer in the Human Rights Campaign Foundation’s 2020 Health Care Equality Index
This product will be delivered within 1-3 business days.
Table of Contents
Chapter 1. Methodology and Scope
Chapter 2. Executive Summary
Chapter 3. Market Variables, Trends, & Scope
Chapter 4. U.S. Sex Reassignment Surgery Market: Gender Transition Estimates & Trend Analysis
Chapter 5. U.S. Sex Reassignment Surgery Market: Procedure Estimates & Trend Analysis
Chapter 6. Competitive Landscape
List of Tables
List of Figures
Companies Mentioned
- Icahn School of Medicine at Mount Sinai
- Transgender Surgery Institute
- Cedars-Sinai
- Moein Surgical Arts
- Cleveland Clinic
- CNY Cosmetic & Reconstructive Surgery
- Plastic Surgery Group of Rochester
- Regents of the University of Michigan
- Boston Medical Center
- The Johns Hopkins University
- Kaiser Permanente
- University of California, San Francisco Center of Excellence for Transgender Health
- New York Presbyterian Hospital
- Mayo Clinic (Transgender and Intersex Specialty Care Clinic)
Methodology
LOADING...
Table Information
| Report Attribute | Details |
|---|---|
| No. of Pages | 89 |
| Published | August 2023 |
| Forecast Period | 2022 - 2030 |
| Estimated Market Value ( USD | $ 2.1 Billion |
| Forecasted Market Value ( USD | $ 5 Billion |
| Compound Annual Growth Rate | 11.2% |
| Regions Covered | United States |
| No. of Companies Mentioned | 14 |
